Benign neoplasm: Parathyroid gland

CD2_BENIGN_PARATHYROID

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D35.1&
Hospital discharge: ICD-9 2271
Cause of death: ICD-10 D35.1&
Cause of death: ICD-9 2271

2 out of 7 registries used, show all original rules.

305

diagram downward connector

Check minimum number of events None

305

diagram downward connector

Include endpoints None

305

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

300

diagram downward connector
CD2_BENIGN_PARATHYROID

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D35
Name in latin Neoplasma benignum glandulae parathyreoideae

Similar endpoints

List of similar endpoints to Benign neoplasm: Parathyroid gland based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 300 209 91
Unadjusted prevalence (%) 0.07 0.09 0.05
Mean age at first event (years) 59.87 59.38 60.98

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_BENIGN_PARATHYROID – Benign neoplasm: Parathyroid gland
GWS hits: 1

Survival analyses between endpoints

Plot

before Benign neoplasm: Parathyroid gland
after Benign neoplasm: Parathyroid gland

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Benign neoplasm: Parathyroid gland

Endpoint not on priority list, no data to show.